Trademark: 79311991
Word
KLICKMER
Status
Registered
Status Code
700
Status Date
Tuesday, May 24, 2022
Serial Number
79311991
Registration Number
6720843
Registration Date
Tuesday, May 24, 2022
Mark Type
4000
Filing Date
Friday, February 5, 2021
Published for Opposition
Tuesday, February 22, 2022

Trademark Owner History
Immudex ApS - Original Registrant

Classifications
5 Preparations for pharmaceutical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; preparations for medical purposes for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancer, T-cell lymphoma, T-cell infiltration of solid tumors and tissue, T-cell diseases in blood, transplantation related diseases and diseases related to immune suppression, autoimmune disease and infectious diseases; diagnostic preparations for medical purposes; reagents for medical and veterinary purposes; vaccines; chemical preparations for analysis for medical diagnostic purposes in relation to vaccines, immunotherapeutics and cellular therapies, including cancer vaccines and immunotherapeutics, borrelia vaccines, TB-vaccines, HIV-vaccines and CMV-vaccines, T-cell therapies, and for use in connection with cancer therapy and other medical therapies, for analysis and treatment of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for infectious diseases, and for use in connection with medical procedures and diagnosis, namely, transplantation, immune monitoring, and vaccines and T-cell monitoring
1 Chemicals used in diagnostics, industry and science, other than for medical or veterinary purposes; diagnostic and research reagents for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic kits for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes consisting primarily of MHC multimer reagents, monoclonal antibodies, reagents, diagnostic agents, control reagents, DNA/RNA oligo's and DNA/RNA oligo conjugated reagents; assays for research and diagnostic purposes other than medical or veterinary diagnostic purposes; biochemical reagents used for non-medical purposes; chemical preparations for analysis for research purposes related to vaccines and immunotherapy, cancer vaccines, borrelia vaccines, TB-vaccines, HIV-vaccines, CMV-vaccines and other vaccines, and for analysis for research purposes of T-cell lymphoma, T-cell infiltration of solid tumors and tissue, and for analysis for research purposes of infectious diseases, autoimmunity and for use in connection with toxicological studies and research in relation to transplantation, immune monitoring, vaccines and T-cell monitoring; chemical reagents other than for medicinal and veterinary purposes

Trademark Events
Apr 14, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 14, 2023
Teas Change Of Correspondence Received
Apr 14, 2023
Teas Change Of Domestic Representatives Address
Apr 14, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 14, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 14, 2023
Teas Change Of Owner Address Received
Apr 2, 2023
New Representative At Ib Received
Oct 3, 2022
Final Decision Transaction Processed By Ib
Sep 9, 2022
Final Disposition Notice Sent To Ib
Sep 9, 2022
Final Disposition Processed
Aug 24, 2022
Final Disposition Notice Created, To Be Sent To Ib
May 24, 2022
Notice Of Registration Confirmation Emailed
May 24, 2022
Registered-Principal Register
Feb 22, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 22, 2022
Published For Opposition
Feb 20, 2022
Notification Processed By Ib
Feb 2, 2022
Notification Of Possible Opposition Sent To Ib
Feb 2, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 2, 2022
Notification Of Notice Of Publication E-Mailed
Jan 20, 2022
Approved For Pub - Principal Register
Jan 13, 2022
Teas/Email Correspondence Entered
Jan 13, 2022
Correspondence Received In Law Office
Jan 13, 2022
Teas Response To Office Action Received
Oct 4, 2021
Refusal Processed By Ib
Sep 13, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Sep 13, 2021
Refusal Processed By Mpu
Sep 1, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Aug 31, 2021
Non-Final Action Written
Aug 30, 2021
Assigned To Examiner
Jun 8, 2021
Application Filing Receipt Mailed
Jun 2, 2021
New Application Office Supplied Data Entered
May 27, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24